Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: Clinical and research implications

Journal of Asthma

Volumn 36, Issue 6, 1999, Pages 477-486

  Wolthers, Ole D ^b   Honour, John W ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b NONE   (Denmark)

Author keywords

Asthma; Beclomethasone dipropionate; Budesonide; Cortisol; Flunisolide; Fluticasone propionate; Hypothalamic pituitary adrenal function; Inhaled glucocorticoids; Triamcinolone acetonide

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; TRIAMCINOLONE ACETONIDE;

ADRENAL GLAND; ASTHMA; CORTICOSTEROID THERAPY; DOSE RESPONSE; FUNCTIONAL ASSESSMENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; OUTCOMES RESEARCH; REVIEW;

EID: 0032846437     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909909054553     Document Type: Review

References (119)

1. Brown HB, Storey G: Beclomethasone dipropionate steroid aerosol in treatment of perennial allergic asthma in children. Br Med J 3:161 (1973).
2. Prahl P, Wilken-Jensen K, Mygind N: Beclomethasone dipropionate aerosol in treatment of hay fever in children. Arch Dis Child 50:875 (1975).
3. Todd G, Dunlop K, McNaboe J, Ryan MF, Carson D, Shields MD: Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 348:27 (1996).
4. Wolthers OD, Hansen M, Juul A, Nielsen HK, Pedersen S: Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids. Pediatr Res 41:44 (1997).
5. Pedersen S, Steffensen G, Ekman I, Tönneson M, Borgå O: Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol 31:579 (1987).
6. Edsbäcker S, Andersson K-E, Ryrfeldt Å: Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol 29:477 (1985).
7. Chaplin MD, Cooper WC, Segre EJ, Dren J, Jones RE, Nerenberg C: Correlation of flunisolide plasma levels to eosinopenic response in humans. J Allergy Clin Immunol 65:445 (1980).
8. Williams SJ: Side effects of inhaled steroids. In Glucocorticosteroids and Mechanisms of Asthma (Hargreave FE, Hogg JC, Malo JL, Toogood JH, editors). Excerpta Medica, Amsterdam, 1989, pp. 68-81.
9. Barnes PJ: Inhaled glucocorticoids for asthma. N Engl J Med 332:868 (1995).
10. Russell G: Inhaled corticosteroid therapy in children: an assessment of the potential for side effects. Thorax 49:1185 (1994).
11. Ayres JG, Barnes PJ, Bellamy D, et al: The British Guidelines for asthma. Thorax 52:1 (1997).
12. Clark DJ, Lipworth BJ: Dose-response of inhaled drugs in asthma. Clin Pharmacokinet 32:58 (1997).
13. Honour JW: The adrenal cortex. In Clinical Paediatric Endocrinology (Brook CDG, editor). Blackwell Scientific Publications, Oxford, 1995, pp. 434-452.
14. Esteban NY, Yergey AL: Cortisol production rates by liquid chromatography-mass spectrometry. Steroids 55:152 (1990).
15. Honour JW, Kelnar CJH, Brook CGD: Urine steroid excretion rates in childhood reflect growth and activity of the adrenal cortex. Acta Endocrine 134:219 (1990).
16. Klein R, Waldman D. Kershnar H, et al: Treatment of chronic childhood asthma: I. A double-blind crossover trial in non-steroid dependent patients. Pediatrics 60:7 (1977).
17. Williams H, Read GF, Verrier-Jones ER, Hughes IA: Effect of inhaled beclomethasone dipropionate on saliva cortisol concentrations. Arch Dis Child 59:553 (1984).
18. Varsano I, Volovitz B, Malik H, Amir Y: Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 85:914 (1990).
19. Wyatt R, Wascher J, Weinberger M, Sherman B: Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary-adrenal function in children with chronic asthma. N Engl J Med 299:1387 (1978).
20. Vaz R, Senior B, Morris M, Binkiewicz A: Adrenal effects of beclomethasone inhalation therapy in asthmatic children. J Pediatr 100:660 (1982).
21. Godfrey S, König P: Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Arch Dis Child 49:591 (1974).
22. Goldstein DE, König P: Effect of inhaled beclomethasone dipropionate on hypothalamic-pituitary-adrenal axis function in children with asthma. Pediatrics 72:60 (1983).
23. Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CGD: The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 130:475 (1991).
24. Broide J, Soferman R, Kivity S, Golander A, Dickstein G, Spirer Z, Weisman Y: Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 80:1243 (1995).
25. Baran D: A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br J Dis Chest 81:171 (1987).
26. Gleeson JGA, Price JF: Controlled trial of budesonide given by the Nebuhaler in preschool children with asthma. Br Med J 297:163 (1988).
27. Sly RM, Imseis M, Frazer M, Joseph F: Treatment of asthma in children with triamcinolone acetonide aerosol. J Allergy Clin Immunol 62:76 (1978).
28. Boe J, Bakke P, Rödelön T, Skovlund E, Gulsvik A: High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Eur Respir J 7:2179 (1994).
29. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL: A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 6:877 (1993).
30. Leblanc P, Mink S, Keistinen T, Saareleinen PA, Ringdal N, Payne SL: A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma. Allergy 49:380 (1994).
31. Ayres JG, Bateman ED, Lundback B, Harris TA: High dose fluticasone propionate, 1 mg daily versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 8:579 (1995).
32. Langdon CG, Thompson J: A multicentre study to compare the efficacy and safety of inhaled fluticasone propionate and budesonide via metered-dose inhalers in adults with mild-to-moderate asthma. Br J Clin Res 5:73 (1994).
33. Langdon CG, Capsey LJ: Fluticasone propionate and budesonide in adult asthmatics: a comparison using drypowder inhaler devices. Br J Clin Res 5:85 (1994).
34. Conolly A: A comparison of fluticasone propionate 100 μg twice daily with budesonide 200 μg twice daily via their respective powder devices in the treatment of mild asthma. Eur J Clin Res 7:15 (1995).
35. Peden DB, Berger WE, Noonan MJ, et al: Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 102:32 (1998).
36. Lundback B, Alexander M, Day J, et al: Evaluation of fluticasone propionate (500 μg/day) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg/day) administered by pressurized inhaler. Respir Med 87:609 (1993).
37. Hoekx JCM, Hedlin G, Pedersen W, Sorva R, Hollingworth K, Efthimiou J: Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 μg/day. Eur Respir J 9:2263 (1996).
38. Law CM, Marchant JL, Honour JW, Preece MA, Warner JO: Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet i:942 (1986).
39. Tabachnik E, Zadik Z: Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr 118: 294 (1991).
40. Phillip M, Aviram M, Leiberman E, Zadik Z, Giat Y, Levy J, Tal A: Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulm 12:84 (1992).
41. Nicolaizik WH, Marchant JL, Preece MA, Warner JO: Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med 150:624 (1994).
42. Brown PH, Bludell G, Greening AP, Crompton GK: Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high-dose inhaled corticosteroids. Respir Med 85:511 (1991).
43. Grahnen A, Jansson B, Brundin RM, et al: A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler. Eur J Clin Pharmacol 52:261 (1997).
44. Selroos O, Halme M: Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and a dry powder inhaler. Thorax 46:891 (1991).
45. Bisgaard H, Pedersen S, Nielsen MD, Østerballe O: Adrenal function in asthmatic children treated with inhaled budesonide. Acta Paediatr Scand 80:213 (1991).
46. Bisgaard H, Nielsen MD, Andersen P, et al: Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 81:1088 (1988).
47. Pedersen S, Fuglsang G: Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J 1:433 (1988).
48. Prahl P, Jensen T: Decreased adreno-cortical suppression utilizing the nebuhaler for inhalation of steroid aerosols. Clin Allergy 17:393 (1987).
49. Agertoft L, Pedersen S: Importance of inhalation device on the effect of budesonide. Arch Dis Child 69: 130 (1993).
50. Wolthers OD, Pedersen S: Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. Respir Med 89:347 (1995).
51. Hoekstra MO, Grol MH, Bouman K, Stijnen T, Koeter GH, Kauffman HF, Gerritsen J: Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med 154:1039 (1996).
52. Goldberg S, Algur N, Levi M, Brukheimer E, Hirsch HJ, Brandski D, Kerem E: Adrenal suppression among young asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol 76: 234 (1996).
53. Zeitlin S, Wood P, Evans A, Radford M: Overnight urine growth hormone, cortisol and adenosine 3′5′cyclic monophosphate excretion in children with chronic asthma treated with inhaled beclomethasone dipropionate. Respir Med 87:445 (1993).
54. Gonzalez PYE, Mintegui J, Garmendia A, Callen M, Reguilon MJ, Garrido A, Emparanza JI: The excretion of free cortisol in the urine in healthy children and in asthmatics treated with long-term inhaled glucocorticoids. Ann Esp Pediatr 44:531 (1996).
55. Doull IJ, Freezer NJ, Holgate ST: Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 151:1715 (1995).
56. Goldberg S, Algur N, Levi M, et al: Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol 76:234 (1996).
57. Volovitz B, Amir J, Malik H, Kauschansky A, Varsano I: Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 329:1703 (1993).
58. Volovitz B, Kauschansky A, Nussinovitch M, Harel L, Varsano I: Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide. J Allergy Clin Immunol 96: 874 (1995).
59. Lipworth BJ, Clark DJ, McFarlane LC: Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via large volume spacer to asthmatic school children. Thorax 52:686 (1997).
60. Clark DJ, Clark RA, Lipworth BJ: Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax 51:941 (1996).
61. Chervinsky P, van As A, Bronsky EA, et al: Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 94:676 (1994).
62. Wilson AM, McFarlane LC, Lipworth BJ: Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. J Clin Endocrinol Metab 83:922 (1997).
63. Yiallouros PK, Milner AD, Conway E, Honour JW: Adrenal function and high dose inhaled corticosteroids for asthma. Arch Dis Child 76:405 (1997).
64. Springer C, Avital A, Maayan CH, Rosler A, Godfrey S: Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch Dis Child 62:815 (1987).
65. Altman LC, Findlay SR, Lopez M, et al: Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Chest 101:1250 (1992).
66. Dickson W, Hall CA, Ellis M, Horrocks RH: Beclomethasone dipropionate aerosol in childhood asthma. Arch Dis Child 48:671 (1973).
67. Field HV, Jenkinson PMA, Frame MH, Warner JO: Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler. Arch Dis Child 57:864 (1982).
68. Kershnar H, Klein K, Waldman D, et al: Treatment of chronic childhood asthma with beclomethasone dipropionate aerosols: II. Effect on pituitary-adrenal function after substitution for oral corticosteroids. Pediatrics 62:189 (1978).
69. Ruiz RG, Price JF: Growth and adrenal responsiveness with budesonide in young asthmatics. Respir Med 88:17 (1994).
70. Clark DJ, Lipworth BJ: Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Chest 112:1248 (1997).
71. Murphy H, Livesy J, Espiner EA, Donald RA: The low dose ACTH test - a further word of caution. J Clin Endocrinol Metab 83:712 (1998).
72. Shapiro GG: Corticosteroids in the treatment of allergic disease: Principles and practice. Pediatr Clin North Am 30:955 (1983).
73. Byron MA, Jackson J, Ansell BM: Effect of different corticosteroid regimens on hypothalamic-pituitary-adrenal axis and growth in juvenile chronic arthritis. J R Soc Med 76:452 (1983).
74. Bacon GE, Spencer ML: Pediatric uses of steroids. Med Clin North Am 57:1265 (1973).
75. Katsunuma T, Akasawa A, Ikura Y: Adrenal function of children with bronchial asthma treated with beclomethasone dipropionate. Ann Allergy 69:529 (1992).
76. Meltzer EO, Kemp JP, Welch MJ, Orgel HA: Effect of dosing schedule on efficacy of beclomethasone dipropionate aerosol in chronic asthma. Am Rev Respir Dis 131:732 (1985).
77. Freigang B, Ashford DR: Adrenal cortical function after long-term beclomethasone aerosol therapy in early childhood. Ann Allergy 64:342 (1990).
78. Katz RM, Rachelefsky GS, Siegel SC, Spector SL, Rhor AS: Twice daily beclomethasone dipropionate in the treatment of childhood asthma. J Asthma 23: 1 (1986).
79. Chang CC, Tam AY: Suppression of adrenal function in children on inhaled steroids. J Paediatr Child Health 27:232 (1991).
80. Gaddie J, Reid IW, Skinner C, Petrie GR, Sinclair DJM, Palmer KNV: Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma: Lancet ii:280 (1973).
81. Ebden P, Jenkins A, Houston G, Davies BH: Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 μg/day) and budesonide (1600 μg/day), for chronic asthma. Thorax 41:869 (1986).
82. Pedersen S: Safety of inhaled glucocorticosteroids. In Glucocorticoids and Mechanisms of Asthma (Hargreave FE, Hoff JC, Malo JL, Toogood JH, editors). Excerpta Medica, Amsterdam, 1989, pp. 40-51.
83. Prahl P: Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exper Allergy 21:145 (1991).
84. MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havnen J, Crescenzi K: A placebo controlled trial of fluticasone propionate in asthmatic children. Eur J Pediatr 152:856 (1993).
85. Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E: Comparison of the efficacy and safety of inhaled fluticasone propiona te 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild and moderate asthma. Arch Dis Child 69:206 (1993).
86. Grahnén A, Eckernäs SÅ, Brundin RM, Ling-Andersson A: An assessment of the systemic activity of single doses of fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 38:521 (1994).
87. Boorsma M, Andersson N, Larsson P, Ullman A: Assessment of the relative systemic potency of inhaled fluticasone propionate and budesonide. Eur Respir J 9:1427 (1996).
88. Wilson AM, McFarlane LC, Lipworth BJ: Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Crit Care Med 156:1274 (1997).
89. Johansson S, Andersson KE, Brattsand R, Gruvstad E, Hedner P: Topical and systemic glucocorticoid potencies of budesonide and beclomethasone in man. Eur J Clin Pharmacol 22:523 (1982).
90. Brown PH, Matusiewicz SP, Shearing C, Tibi L, Greening AP, Crompton GK: Systemic effects of high dose inhaled steroids: a comparison of beclomethasone dipropionate (BDP) and budesonide (BUD). Thorax 48:845 (1992).
91. Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C: Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 48:817 (1993).
92. Agertoft L, Pedersen S: Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. Eur Respir J 10:1507 (1997).
93. Agertoft L, Pedersen S: A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 99:773 (1997).
94. Clark D, Grove A, Cargill RI, Lipworth BJ: Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 51:262 (1996).
95. Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ: Adrenocortical activity with repeated administration of once-daily inhaled fluticasone propionate and budesonide in asthmatic adults. Eur J Clin Pharmacol 53:317 (1998).
96. Clark DJ, Lipworth BJ: Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax 52:55 (1997).
97. Farrer M, Francis AJ, Pearce SJ: Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750 ml spacing device. Thorax 45:740 (1990).
98. Brown PH, Blundell G, Greening AP, Crompton GK: Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 45:736 (1990).
99. Meibohm B, Hochhaus G, Rohatagi S, et al: Dependency of cortisol suppression on the administration time of inhaled corticosteroids. J Clin Pharmacol 37: 704 (1997).
100. Nikolaizik WH, Marchant JL, Preece MA, Warner JO: Nocturnal cortisol secretion in healthy adults before and after inhalation of budesonide. Am J Respir Crit Care Med 153:97 (1996).
101. Jones AH, Langdon CG, Lee PS, et al: Pulmicort Turbuhaler once daily as initial prophylactic treatment for asthma. Respir Med 88:293 (1994).
102. Aaronson D, Kaiser H, Dockhorn R, et al: Effects of budesonide by means of the Turbuhaler on the hypothalamic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. J Allergy Clin Immunol 101:312 (1998).
103. Brannan MD, Herron JM, Reidenberg P, Affrime MB: A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations. Ann Allergy Asthma Immunol 80:39 (1998).
104. Grebe SK, Peek CM, Durham JA, Kljakovic M, Cooke RR: Inhaled beclomethasone dipropionate suppresses the hypothalamo-pituitary-adrenal axis in a dose dependent manner. Clin Endocrinol 47:297 (1997).
105. Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 44:151 (1996).
106. Crowley S, Hindmarsh PC, Honour JW, Brook CGD: Reproducibility of the cortisol response to stimulation with a low dose of ACTH (1-24): the effect on basal cortisol levels in comparison of low dose with high dose secretory dynamics. J Endocrinol 136:167 (1993).
107. Gordon ACH, McDonald CF, Thomson SA, Frame MH, Pottage A, Crompton GK: Acute adrenal insufficiency associated with high dose inhaled steroids. Br Med J 304:1415 (1992).
108. Hollman GA, Allen DB: Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 81: 452 (1988).
109. Wolthers OD, Honour JW: Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids. Clin Exper Allergy 28:545 (1998).
110. Griffin JP: Drug induced allergic and hypersensitiv-ity reactions. Practitioner 227:1283 (1983).
111. Forest MG: Adrenal function tests. In Functional Endocrinologic Diagnostics in Children and Adolescents (Ranke MB, editor). J & J Verlag, Mannheim, 1992, pp. 248-274.
112. Shah A, Stanhope R, Matthew D: Hazards of pharmacological tests of growth hormone secretion in childhood. Br Med J 304:173 (1992).
113. Lipwoth BJ, Seckl JR: Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 52:476 (1997).
114. McIntyre HD, Mitchell CA, Bowler SD, Armstrong JG, Wooler JA, Cowley DM: Measuring the systemic effect of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens. Thorax 50:1280 (1995).
115. Priftis K, Milner AD, Conway E, Honour JW: Adrenal function in asthma. Arch Dis Child 65:838 (1990).
116. Heuck C, Wolthers OD, Hansen M, Kollerup G: Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 62:659 (1997).
117. Wolthers OD, Juul A, Hansen M, Müller J, Pedersen S: The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide. Acta Paediatr 84:393 (1995).
118. Wolthers OD: Long, intermediate, and short term growth studies in asthmatic children treated with inhaled glucocorticosteroids. Eur Res J 9:821 (1996).
119. Heuck C, Wolthers OD: A placebo-controlled study of three osteocalcin assays for assessment of prednisolone-induced suppression of bone turnover. J Endocrinol 159:127 (1998).